Title |
Single-cell RNAseq for the study of isoforms—how is that possible?
|
---|---|
Published in |
Genome Biology, August 2018
|
DOI | 10.1186/s13059-018-1496-z |
Pubmed ID | |
Authors |
Ángeles Arzalluz-Luque, Ana Conesa |
Abstract |
Single-cell RNAseq and alternative splicing studies have recently become two of the most prominent applications of RNAseq. However, the combination of both is still challenging, and few research efforts have been dedicated to the intersection between them. Cell-level insight on isoform expression is required to fully understand the biology of alternative splicing, but it is still an open question to what extent isoform expression analysis at the single-cell level is actually feasible. Here, we establish a set of four conditions that are required for a successful single-cell-level isoform study and evaluate how these conditions are met by these technologies in published research. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 20 | 25% |
Spain | 8 | 10% |
Australia | 8 | 10% |
France | 7 | 9% |
United Kingdom | 7 | 9% |
Germany | 3 | 4% |
Venezuela, Bolivarian Republic of | 2 | 2% |
South Africa | 1 | 1% |
Norway | 1 | 1% |
Other | 4 | 5% |
Unknown | 20 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 50 | 62% |
Members of the public | 28 | 35% |
Practitioners (doctors, other healthcare professionals) | 1 | 1% |
Science communicators (journalists, bloggers, editors) | 1 | 1% |
Unknown | 1 | 1% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 306 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 74 | 24% |
Researcher | 47 | 15% |
Student > Master | 29 | 9% |
Student > Bachelor | 27 | 9% |
Student > Doctoral Student | 13 | 4% |
Other | 48 | 16% |
Unknown | 68 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 98 | 32% |
Agricultural and Biological Sciences | 62 | 20% |
Computer Science | 20 | 7% |
Medicine and Dentistry | 15 | 5% |
Neuroscience | 10 | 3% |
Other | 26 | 8% |
Unknown | 75 | 25% |